Search results
Pfizer Quadruples Its Covid Shot Price — And Other Vaccine Stocks Rocket
Investor's Business Daily· 2 years agoModerna snagged an upgrade Friday on the likelihood it will follow in Pfizer's footsteps in hiking...
With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?
Motley Fool· 9 months agoThe Food and Drug Administration (FDA) just approved the updated Omicron-adapted COVID-19 booster...
Undervalued Biotech Stocks Shine: Pfizer and BioNTech Show Resilience
GuruFocus.com via Yahoo Finance· 8 months agoIn the ever-evolving world of the stock market, uncovering potential gold mines is paramount for...
Pfizer (PFE), BioNTech Seek EU Nod for Omicron-Based COVID Jab
Zacks via Yahoo Finance· 2 years agoPfizer (PFE) and BioNTech (BNTX) complete a regulatory filing for their Omicron-specific bivalent...
Pfizer Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid
Investor's Business Daily· 8 months agoPfizer is hiking its Paxlovid price to $1,390 for a five-day course — more than double what the U.S....
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
Investor's Business Daily· 8 months agoModerna stock and BioNTech led a sell-off Monday among Covid vaccine makers after Pfizer slashed...
The Covid Gambit: Pfizer, Moderna Struggle To Get The Jump On Covid
Investor's Business Daily· 2 years agoPfizer, BioNTech and Moderna are working feverishly to launch new Covid boosters ahead of a fall...
Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions
Investor's Business Daily· 2 years agoThe Biden administration is planning to stop paying for Covid vaccines and treatments, shifting the...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 1 month agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Pfizer (PFE) Q4 Earnings Top, 2023 View Disappoints, Stock Down
Zacks via Yahoo Finance· 1 year agoPfizer PFE reported fourth-quarter 2022 adjusted earnings per share of $1.14, which significantly...